首页 > 最新文献

World Journal of Cardiovascular Surgery最新文献

英文 中文
Importance of LV Venting after ECMO Implantation in Post-Cardiotomy Syndrome: A Case Report ECMO植入后左室通气在心脏切开综合征中的重要性:1例报告
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.129016
V. Hajiyev, T. Erkenov, Elgun Hajiyev, A. Bauer, A. Smechowski, S. Musayev, D. Fritzsche
{"title":"Importance of LV Venting after ECMO Implantation in Post-Cardiotomy Syndrome: A Case Report","authors":"V. Hajiyev, T. Erkenov, Elgun Hajiyev, A. Bauer, A. Smechowski, S. Musayev, D. Fritzsche","doi":"10.4236/wjcs.2022.129016","DOIUrl":"https://doi.org/10.4236/wjcs.2022.129016","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"27 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78418213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Transthoracic First Rib Resection for Neurogenic Thoracic Outlet Syndrome 机器人经胸第一肋骨切除术治疗神经源性胸廓出口综合征
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.121001
F. Gharagozloo, M. Meyer
{"title":"Robotic Transthoracic First Rib Resection for Neurogenic Thoracic Outlet Syndrome","authors":"F. Gharagozloo, M. Meyer","doi":"10.4236/wjcs.2022.121001","DOIUrl":"https://doi.org/10.4236/wjcs.2022.121001","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85623211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Etiological Factors of Infective Endocarditis in Children Aged 1 Month to 15 Years Hospitalised in the Paediatric Department of CHU Gabriel Touré of Bamako (Mali) 马里巴马科医院儿科1个月~ 15岁儿童感染性心内膜炎病因分析
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.122002
Maiga Belco, Sacko Karamoko, Konaté Djéneba, Diakité Abdoul Aziz, D. Adama, Cissé Mohamed Elmouloud, DansoKo Nassira, Traoré Kalilou, T. Pierre, Doumbia Abdou Karim, Traoré Fousseini, Diakité Fatoumata Léonie, Sidibé Lalla, Maiga Leila, A. Ibrahim, Coulibaly Oumar, Diall Hawa, Sylla Mariam
{"title":"Etiological Factors of Infective Endocarditis in Children Aged 1 Month to 15 Years Hospitalised in the Paediatric Department of CHU Gabriel Touré of Bamako (Mali)","authors":"Maiga Belco, Sacko Karamoko, Konaté Djéneba, Diakité Abdoul Aziz, D. Adama, Cissé Mohamed Elmouloud, DansoKo Nassira, Traoré Kalilou, T. Pierre, Doumbia Abdou Karim, Traoré Fousseini, Diakité Fatoumata Léonie, Sidibé Lalla, Maiga Leila, A. Ibrahim, Coulibaly Oumar, Diall Hawa, Sylla Mariam","doi":"10.4236/wjcs.2022.122002","DOIUrl":"https://doi.org/10.4236/wjcs.2022.122002","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90499044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Six Years Clinical Experience and Surgical Considerations in Management of Cardiac Myxoma in Iraqi Center for Heart Disease—Single Center Experience 伊拉克心脏中心6年治疗心脏黏液瘤的临床经验及手术考虑-单中心经验
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.128013
Hozhan Hussein Blbas, A. M. Hussein, Muhammad Mahmud Salim, Laith Saleh Alkaaby, A. Taha
Background: Cardiac myxomas are the most frequently encountered benign cardiac tumors that if left untreated are inexorably progressive and potential-ly fatal. Surgery is the only way of treatment, and if not treated with the right surgical technique recurrence occurs. Objectives: In this single center study we documented the patterns of presentation, localization, surgical approaches and outcome of cardiac myxomas. Methods: This is a retrospective study of 20 patients who underwent surgical removal of atrial myxoma from January 2010 to December 2015. All patients underwent general investigations, and echocardiography was performed on all patients and surgery was done using extracorporeal circulation and mild hypothermia. Results: The ages of the patients ranged from 14 years to 71 years, with a mean of 51.45 years. Most myxomas (75%) originated from left atrium, 20% from right atrium and bi-atrial in 5% of cases. The male-to-female ratio was 1:2.3 (14 females and 6 males). Myxomas were more common in blood group A+ and Conclusions: Cardiac myxoma excision account for a very small percentage of cardiac procedures. Immediate surgical treatment is indicated because of high risk of embolization and sudden death. Cardiac myxomas can be excised with a low rate of mortality and morbidity. Follow-up examination, including echocardiography, should be performed regularly.
背景:心脏黏液瘤是最常见的良性心脏肿瘤,如果不及时治疗,将不可避免地发展并可能致命。手术是唯一的治疗方法,如果不采用正确的手术技术,会发生复发。目的:在这项单中心研究中,我们记录了心脏黏液瘤的表现、定位、手术入路和结果。方法:回顾性分析2010年1月至2015年12月接受心房黏液瘤手术切除的20例患者。所有患者都进行了一般检查,并对所有患者进行了超声心动图检查,并使用体外循环和亚低温进行了手术。结果:患者年龄14 ~ 71岁,平均51.45岁。大多数黏液瘤(75%)起源于左心房,20%起源于右心房,5%的病例起源于双心房。男女比例为1:2.3(女性14人,男性6人)。结论:心脏黏液瘤切除术在心脏手术中所占比例很小。由于栓塞和猝死的高风险,应立即手术治疗。心脏黏液瘤可以切除,死亡率和发病率都很低。随访检查,包括超声心动图,应定期进行。
{"title":"Six Years Clinical Experience and Surgical Considerations in Management of Cardiac Myxoma in Iraqi Center for Heart Disease—Single Center Experience","authors":"Hozhan Hussein Blbas, A. M. Hussein, Muhammad Mahmud Salim, Laith Saleh Alkaaby, A. Taha","doi":"10.4236/wjcs.2022.128013","DOIUrl":"https://doi.org/10.4236/wjcs.2022.128013","url":null,"abstract":"Background: Cardiac myxomas are the most frequently encountered benign cardiac tumors that if left untreated are inexorably progressive and potential-ly fatal. Surgery is the only way of treatment, and if not treated with the right surgical technique recurrence occurs. Objectives: In this single center study we documented the patterns of presentation, localization, surgical approaches and outcome of cardiac myxomas. Methods: This is a retrospective study of 20 patients who underwent surgical removal of atrial myxoma from January 2010 to December 2015. All patients underwent general investigations, and echocardiography was performed on all patients and surgery was done using extracorporeal circulation and mild hypothermia. Results: The ages of the patients ranged from 14 years to 71 years, with a mean of 51.45 years. Most myxomas (75%) originated from left atrium, 20% from right atrium and bi-atrial in 5% of cases. The male-to-female ratio was 1:2.3 (14 females and 6 males). Myxomas were more common in blood group A+ and Conclusions: Cardiac myxoma excision account for a very small percentage of cardiac procedures. Immediate surgical treatment is indicated because of high risk of embolization and sudden death. Cardiac myxomas can be excised with a low rate of mortality and morbidity. Follow-up examination, including echocardiography, should be performed regularly.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85427873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitral Valve Surgery for Functional Regurgitation: Insights into Heart Failure and Readmission 二尖瓣手术治疗功能性返流:对心力衰竭和再入院的见解
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.126011
Joseph A. Gancayco, Alexander P. Kossar, C. Chiuzan, I. George
Background: Functional mitral regurgitation (FMR) is a significant burden among our increasingly elderly population. Mitral valve repair (MVr) is the preferred surgical treatment of FMR despite limited evidence supporting its efficacy. Mitral valve replacement (MVR) is the alternative procedure typically reserved for patients who are at higher risk or refractory to MVr. The present study aims to determine which of the two procedures is more effective in the surgical treatment of FMR. Methods: 344 charts of FMR patients who received either MVr (n = 263) or MVR (n = 81) from 2004-2016 at our institution were reviewed. Treatment efficacy was assessed based on heart failure (HF)-readmission and survival rates within 5 years from discharge. Propensity score approach with inverse probability weighting and Cox regression models were employed to evaluate procedural impact on survival and rehospitalizations, respectively. Follow-up echocardiographic data from the original cohort was assessed for differences in metrics between procedural groups at >6 months (MVr: n = 75; MVR: n = 23) and 1 year (MVr: n = 75; MVR: n = 18) post-op. Results: MVR patients had a lower risk of being readmitted for HF within 5 years compared to the MVr group (HR-adj (95% CI): 0.60 (0.41 - 0.88), p = 0.008). MVR patients also had a higher overall risk of death (HR-adj (95% CI): 1.82 (1.05 - 3.16), p = 0.034) but this was border-line significantly different at 5 years cut-off (p = 0.057). Conclusions: Higher HF readmission in MVr patients than in sicker, higher surgical-risk MVR patients reflects the inadequacy of MVr to treat FMR. Novel approaches to MVR may be necessary to adequately manage FMR.
背景:功能性二尖瓣反流(FMR)是我国日益老龄化人口的一个重要负担。二尖瓣修复(MVr)是FMR首选的手术治疗方法,尽管支持其疗效的证据有限。二尖瓣置换术(MVR)是一种可选择的手术,通常用于高危或难治性的患者。本研究旨在确定两种方法中哪一种在FMR手术治疗中更有效。方法:回顾我院2004-2016年344例接受MVr (n = 263)或MVr (n = 81)的FMR患者的病历。治疗效果评估基于心力衰竭(HF)-出院后5年内的再入院率和生存率。采用反概率加权倾向得分法和Cox回归模型分别评估手术对生存率和再住院率的影响。对原始队列的随访超声心动图数据进行评估,以确定手术组在bbb至6个月时的指标差异(MVr: n = 75;MVR: n = 23)和1年(MVR: n = 75;MVR: n = 18)术后。结果:与MVR组相比,MVR患者在5年内因HF再次入院的风险较低(HR-adj (95% CI): 0.60 (0.41 - 0.88), p = 0.008)。MVR患者也有更高的总体死亡风险(HR-adj (95% CI): 1.82 (1.05 - 3.16), p = 0.034),但在5年截止时间(p = 0.057),这是有显著性差异的。结论:MVr患者的HF再入院率高于病情较重、手术风险较高的MVr患者,反映了MVr治疗FMR的不足。为了充分管理FMR,可能需要新的MVR方法。
{"title":"Mitral Valve Surgery for Functional Regurgitation: Insights into Heart Failure and Readmission","authors":"Joseph A. Gancayco, Alexander P. Kossar, C. Chiuzan, I. George","doi":"10.4236/wjcs.2022.126011","DOIUrl":"https://doi.org/10.4236/wjcs.2022.126011","url":null,"abstract":"Background: Functional mitral regurgitation (FMR) is a significant burden among our increasingly elderly population. Mitral valve repair (MVr) is the preferred surgical treatment of FMR despite limited evidence supporting its efficacy. Mitral valve replacement (MVR) is the alternative procedure typically reserved for patients who are at higher risk or refractory to MVr. The present study aims to determine which of the two procedures is more effective in the surgical treatment of FMR. Methods: 344 charts of FMR patients who received either MVr (n = 263) or MVR (n = 81) from 2004-2016 at our institution were reviewed. Treatment efficacy was assessed based on heart failure (HF)-readmission and survival rates within 5 years from discharge. Propensity score approach with inverse probability weighting and Cox regression models were employed to evaluate procedural impact on survival and rehospitalizations, respectively. Follow-up echocardiographic data from the original cohort was assessed for differences in metrics between procedural groups at >6 months (MVr: n = 75; MVR: n = 23) and 1 year (MVr: n = 75; MVR: n = 18) post-op. Results: MVR patients had a lower risk of being readmitted for HF within 5 years compared to the MVr group (HR-adj (95% CI): 0.60 (0.41 - 0.88), p = 0.008). MVR patients also had a higher overall risk of death (HR-adj (95% CI): 1.82 (1.05 - 3.16), p = 0.034) but this was border-line significantly different at 5 years cut-off (p = 0.057). Conclusions: Higher HF readmission in MVr patients than in sicker, higher surgical-risk MVR patients reflects the inadequacy of MVr to treat FMR. Novel approaches to MVR may be necessary to adequately manage FMR.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"111 3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79459501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long Segmenter Reconstruction of Diffusely Diseased of the Left Anterior Descending Artery without Coronary Artery Bypass Grafting 无冠状动脉旁路移植术的左前降支弥漫性病变长节段重建
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.123003
S. Katırcıoğlu, H. Keski̇n
A 58-year-old male patient with LAD diffuse had hyperlipidemia and hypertension. Preoperative angiography showed that he had triple-vessel disease with diffusely diseased LAD. In echocardiography, EF was detected as 60 % (52 70) and PAP 25 (12 25) mmHg and 2 degrees of tricuspid insufficiency. In this case report, we will present our LAD endarterectomy case. Surgical technique: after standard general anesthesia, cardiopulmonary bypass procedure and moderate hypothermia, cold cardioplegic arrest. Longitudinal long LAD endarterectomy was performed (approximately 10 cm long). A dissector was used to develop on the plane between media and atheroma. Gentle traction was made to light off the atheroplaque with the coronary artery branches, distal and proximal part of the LAD. We assumed that the distal part of the LAD was free from plaque. Then we made the same procedure to the proximal part of the LAD. Luckily, we observed that proximal atheroplaque was also harvested. After completing the endarterectomy, antegrade cardioplegia was administrated to wash and any debris is LAD; also we tried the distal part of the LAD. Via retrograde cardioplegia administrated, we did also observe the bolus return of cardioplegia via retrograde way. After making the same coronary end arteriotomy was successful, we used saphenous vein as a patch for LAD reconstruction. We made only patch plasty like a carotid endarterectomy. Postoperative follow-up period was 120 months. According to 8 years angiography result, LAD patch plasty was working relatively well. The patient did not have any complaints. We made coronary angiography 10 years after the operation and observed that our patch plasty was occluded but the patient has still class II symptoms with an EF value of 40%.
男性,58岁,LAD弥漫性高脂血症合并高血压。术前血管造影显示他患有三支血管病变伴弥漫性病变LAD。超声心动图检测EF为60% (52 70),PAP为25 (12 25)mmHg,三尖瓣不全2度。在这个病例报告中,我们将介绍我们的LAD动脉内膜切除术病例。手术技术:经标准全身麻醉、体外循环手术及中低温、冷性心脏骤停。行纵向长LAD动脉内膜切除术(约10cm长)。用解剖器在中膜和动脉粥样硬化之间的平面上显影。轻柔牵引以减轻冠状动脉分支、LAD远端和近端部分的动脉粥样斑块。我们假设LAD远端没有斑块。然后我们对LAD的近端进行了相同的手术。幸运的是,我们观察到近端动脉粥样斑块也被清除。完成动脉内膜切除术后,顺行心脏截止剂冲洗,任何碎片均为LAD;我们还尝试了LAD的远端部分。通过逆行心脏骤停,我们也观察到逆行心脏骤停的大量恢复。在同样的冠状动脉末端切开术成功后,我们使用隐静脉作为LAD重建的补片。我们只做了颈动脉内膜切除术之类的修补手术。术后随访120个月。根据8年的血管造影结果,LAD补片成形术效果较好。病人没有任何主诉。术后10年我们做了冠状动脉造影,观察到我们的补片成形术闭塞,但患者仍然有II类症状,EF值为40%。
{"title":"Long Segmenter Reconstruction of Diffusely Diseased of the Left Anterior Descending Artery without Coronary Artery Bypass Grafting","authors":"S. Katırcıoğlu, H. Keski̇n","doi":"10.4236/wjcs.2022.123003","DOIUrl":"https://doi.org/10.4236/wjcs.2022.123003","url":null,"abstract":"A 58-year-old male patient with LAD diffuse had hyperlipidemia and hypertension. Preoperative angiography showed that he had triple-vessel disease with diffusely diseased LAD. In echocardiography, EF was detected as 60 % (52 70) and PAP 25 (12 25) mmHg and 2 degrees of tricuspid insufficiency. In this case report, we will present our LAD endarterectomy case. Surgical technique: after standard general anesthesia, cardiopulmonary bypass procedure and moderate hypothermia, cold cardioplegic arrest. Longitudinal long LAD endarterectomy was performed (approximately 10 cm long). A dissector was used to develop on the plane between media and atheroma. Gentle traction was made to light off the atheroplaque with the coronary artery branches, distal and proximal part of the LAD. We assumed that the distal part of the LAD was free from plaque. Then we made the same procedure to the proximal part of the LAD. Luckily, we observed that proximal atheroplaque was also harvested. After completing the endarterectomy, antegrade cardioplegia was administrated to wash and any debris is LAD; also we tried the distal part of the LAD. Via retrograde cardioplegia administrated, we did also observe the bolus return of cardioplegia via retrograde way. After making the same coronary end arteriotomy was successful, we used saphenous vein as a patch for LAD reconstruction. We made only patch plasty like a carotid endarterectomy. Postoperative follow-up period was 120 months. According to 8 years angiography result, LAD patch plasty was working relatively well. The patient did not have any complaints. We made coronary angiography 10 years after the operation and observed that our patch plasty was occluded but the patient has still class II symptoms with an EF value of 40%.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74444186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To What Extent Can Transcatheter Devices Replace Open-Heart Surgery in the Treatment of Cardiac Septal Defects? 经导管装置在多大程度上可以替代心内直视手术治疗心间隔缺损?
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.121024
Aathi S. Somanathan
{"title":"To What Extent Can Transcatheter Devices Replace Open-Heart Surgery in the Treatment of Cardiac Septal Defects?","authors":"Aathi S. Somanathan","doi":"10.4236/wjcs.2022.121024","DOIUrl":"https://doi.org/10.4236/wjcs.2022.121024","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75483934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laubry-Pezzi Syndrome in an Adult Male Patient and Its Surgical Correction: A Case Report and Literature Review 成年男性劳布里-佩齐综合征1例及其手术矫正:1例报告及文献复习
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.1210019
Md. Abir Tazim Chowdhury, Md. Zulfiqur Haider, Sohail Ahmed, S. Z. Nine, Arup Khan, Naheed Rayhan, Musfaqus Shalehin, Md. Sifat Uddin, Nakib Shah Alam, Saiful Khan, N. Ahmed, Munama Magdum
{"title":"Laubry-Pezzi Syndrome in an Adult Male Patient and Its Surgical Correction: A Case Report and Literature Review","authors":"Md. Abir Tazim Chowdhury, Md. Zulfiqur Haider, Sohail Ahmed, S. Z. Nine, Arup Khan, Naheed Rayhan, Musfaqus Shalehin, Md. Sifat Uddin, Nakib Shah Alam, Saiful Khan, N. Ahmed, Munama Magdum","doi":"10.4236/wjcs.2022.1210019","DOIUrl":"https://doi.org/10.4236/wjcs.2022.1210019","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84667467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Algorithm for Surgical Decision Making in Patients with Thoracic Outlet Syndrome 胸廓出口综合征患者手术决策的算法
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.121021
F. Gharagozloo
{"title":"Algorithm for Surgical Decision Making in Patients with Thoracic Outlet Syndrome","authors":"F. Gharagozloo","doi":"10.4236/wjcs.2022.121021","DOIUrl":"https://doi.org/10.4236/wjcs.2022.121021","url":null,"abstract":"","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84136703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Treatment of Chronic Constrictive Pericarditis in a Developing Country 发展中国家慢性缩窄性心包炎的外科治疗
Pub Date : 2022-01-01 DOI: 10.4236/wjcs.2022.1211025
K. Souaga, E. Katché, Yoboua Aimé Kirioua-Kamenan, Jean Calaire Degré, K. A. Amani, Gnamien Randolph Niava, J. Kouame, Paul Yapo Yapo, K. Kendja
Background: Chronic constrictive pericarditis is a rare but serious clinical entity with a poor prognosis in the absence of surgical treatment. The purpose of this study was to report on our experience of subtotal anterior peri-cardectomy and analyze our surgical results. Results: We included 74 patients operated on for chronic constrictive pericarditis in our institution during the period from January 1985 to December 2020. There were 29 female and 45 male patients, with an average age of 28 years (range: 8 - 64 years). 36.5% of patients were in NYHA class III or IV. Physical signs were dominated by peripheral signs of right heart failure in 93.2% of cases. The surgical procedure was a subtotal anterior pericardectomy from the left to the right phrenic nerve, freeing the heart chambers and the large vessels. The surgical results were marked by a functional improvement in 82.4% of the cases. The post-operative complications were marked by a low cardiac output in 8.1% of the cases, a atrial fibrillation in 4.1% of the cases, a haemorrhage in 1.4% of the cases, a haemothorax in 2.7% of the cases. Perioperative mortality was 5.4% patients. The causes of death were low cardiac output in 50% of cases, hemorrhage in 25% of cases, and hepatocellular insufficiency in 25% of cases. We observed a mortality of 2.9% after an average follow-up of 5.17 years ± 4.76 years. All other survivors were asymptomatic and no re-intervention for recurrence was performed. Conclusions: Subtotal anterior pericardectomy was the technique we used for the treatment of chronic constrictive pericarditis. It allowed having satisfactory surgical results with a functional improvement and an acceptable morbidity.
背景:慢性缩窄性心包炎是一种罕见但严重的临床疾病,在缺乏手术治疗的情况下预后较差。本研究的目的是报告我们的前心包次全切除术的经验,并分析我们的手术结果。结果:我们纳入了1985年1月至2020年12月在本院手术治疗慢性缩窄性心包炎的74例患者。女性29例,男性45例,平均年龄28岁(范围8 ~ 64岁)。36.5%的患者为NYHA III级或IV级。93.2%的患者以外周性右心衰体征为主。手术过程是前心包次全切,从左膈神经到右膈神经,释放心腔和大血管。82.4%的患者手术后功能得到改善。术后并发症的特点是8.1%的病例出现低心排血量,4.1%的病例出现心房颤动,1.4%的病例出现出血,2.7%的病例出现血胸。围手术期死亡率为5.4%。死亡原因为50%的病例心排血量低,25%的病例出血,25%的病例肝细胞功能不全。平均随访5.17年±4.76年,死亡率为2.9%。所有其他幸存者均无症状,未进行复发再干预。结论:前心包膜次全切术是治疗慢性缩窄性心包炎的有效方法。它允许在功能改善和可接受的发病率方面取得令人满意的手术结果。
{"title":"Surgical Treatment of Chronic Constrictive Pericarditis in a Developing Country","authors":"K. Souaga, E. Katché, Yoboua Aimé Kirioua-Kamenan, Jean Calaire Degré, K. A. Amani, Gnamien Randolph Niava, J. Kouame, Paul Yapo Yapo, K. Kendja","doi":"10.4236/wjcs.2022.1211025","DOIUrl":"https://doi.org/10.4236/wjcs.2022.1211025","url":null,"abstract":"Background: Chronic constrictive pericarditis is a rare but serious clinical entity with a poor prognosis in the absence of surgical treatment. The purpose of this study was to report on our experience of subtotal anterior peri-cardectomy and analyze our surgical results. Results: We included 74 patients operated on for chronic constrictive pericarditis in our institution during the period from January 1985 to December 2020. There were 29 female and 45 male patients, with an average age of 28 years (range: 8 - 64 years). 36.5% of patients were in NYHA class III or IV. Physical signs were dominated by peripheral signs of right heart failure in 93.2% of cases. The surgical procedure was a subtotal anterior pericardectomy from the left to the right phrenic nerve, freeing the heart chambers and the large vessels. The surgical results were marked by a functional improvement in 82.4% of the cases. The post-operative complications were marked by a low cardiac output in 8.1% of the cases, a atrial fibrillation in 4.1% of the cases, a haemorrhage in 1.4% of the cases, a haemothorax in 2.7% of the cases. Perioperative mortality was 5.4% patients. The causes of death were low cardiac output in 50% of cases, hemorrhage in 25% of cases, and hepatocellular insufficiency in 25% of cases. We observed a mortality of 2.9% after an average follow-up of 5.17 years ± 4.76 years. All other survivors were asymptomatic and no re-intervention for recurrence was performed. Conclusions: Subtotal anterior pericardectomy was the technique we used for the treatment of chronic constrictive pericarditis. It allowed having satisfactory surgical results with a functional improvement and an acceptable morbidity.","PeriodicalId":23646,"journal":{"name":"World Journal of Cardiovascular Surgery","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85681932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1